Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1
The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries. The start of the new year is typically a time when people make big...
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%
A twice-yearly injection reduces the risk of HIV infection by 96%. That’s according to a clinical trial led by physicians at Emory University and the Grady Health System.
China’s NMPA prioritises HUTCHMED’s lung cancer therapy review
China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application (NDA) for HUTCHMED’s ORPATHYS (savolitinib) and ...
Testing Services Market Outlook, 2025-2035
Testing Services Market Outlook, 2025-2035 - Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services
IIT Guwahati and Bose Institute develop injectable hydrogel for cancer
The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel designed to release anti-cancer therapies to tumou...
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise.
XBiotech halts all rheumatology research after missing Phase II endpoints
The Texas-based company has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities. XBiotech’s stock price has taken a hit after it announced ...
Novo gets the green light for once-daily haemophilia drug following setbacks
Haemophilia is a rare condition that affects the blood’s ability to clot.
Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity
Tirzepatide (Zepbound; Eli Lilly) is now approved for the treatment of moderate-to-severe obstructive sleep apnea (OSA) with obesity, the Food and Drug Administration announced late la...
Endo Recalls Adrenalin Chloride Solution
In a press release posted on FDA’s website, Endo USA, Inc. announced it was voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1...
FDA Awards Fast Track Designation to Staphylococcus aureus Vaccine Candidate
The FDA granted fast track designation (FTD) to a multivalent toxoid vaccine candidate from LimmaTech, LBT-SA7, which is designed to prevent skin and soft tissue infections (SSTIs) cau...
Mirroring Merck's problem, GSK's Jemperli-Zejula study in ovarian cancer misses survival goal
Two clinical trials by Merck and GSK both failed on their key secondary endpoints of overall survival in ovarian cancer. Perhaps PD-1 inhibitors just aren’t for ovarian cancer after all.
72
73
74
75
76
77
78
79
80
